An investigation of some side effects in 47 psychotic patients during treatment with clozapine and discontinuing of the treatment.
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001799:Blood Sedimentation; D056486:Chemical and Drug Induced Liver Injury; D003024:Clozapine / Q000009:adverse effects*; D003404:Creatinine / Q000097:blood; D003984:Dibenzazepines / Q000009:adverse effects*; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy*; D000516:alpha-Amylases / Q000097:blood; D005723:gamma-Glutamyltransferase / Q000097:blood
D003984:Dibenzazepines; D006454:Hemoglobins; D003404:Creatinine; D007770:L-Lactate Dehydrogenase; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D000516:alpha-Amylases; D003024:Clozapine; D001663:Bilirubin